Estrogen with interrupted progestin HRT: a review of experimental and clinical studies (Q33861541)

29 July 2017

1 reference

title

Estrogen with interrupted progestin HRT: a review of experimental and clinical studies (English)

1 reference

Hormone Replacement Therapy

29 July 2017

1 reference

Casper RF

1

1 reference

29 July 2017

1 February 2000

1 reference

29 July 2017

1 reference

29 July 2017

34

1 reference

29 July 2017

2

1 reference

29 July 2017

97-108

1 reference

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Prevalence and determinants of estrogen replacement therapy in elderly women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Compliance with hormonal replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Compliance with hormone replacement therapy: Are women receiving the full impact of hormone replacement therapy preventive health benefits?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Predominance of early endometrial cancers after long-term estrogen use

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Oestrogen use and survival in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Integrated control of cell proliferation and cell death by the c-myc oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Progestin regulation of cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Menopausal Estrogen Replacement Therapy and Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Decreased mortality in users of estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

The cyclic pattern of the immunocytochemical expression of oestrogen and progesterone receptors in human myometrial and endometrial layers: characterization of the endometrial-subendometrial unit

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Estrogen and progesterone receptors in the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Progesterone-mediated suppression of estradiol receptors in cynomolgus macaque cervix, endometrium and oviduct during sequential estradiol-progesterone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Differential gene regulation by estrogen and progesterone in the primate endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Oral contraceptives, lipoproteins, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Oestradiol up-regulates oestrogen receptor, cyclophilin, and glyceraldehyde phosphate dehydrogenase mRNA concentrations in endometrium, but down-regulates them in liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Estradiol up-regulates estrogen receptor-alpha messenger ribonucleic acid in sheep endometrium by increasing its stability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Rapid recovery of nuclear estrogen receptor and oxytocin receptor in the ovine uterus following progesterone withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Progesterone regulation of endometrial estrogen receptor and cell proliferation during the late proliferative and secretory phase in artificial menstrual cycles in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Rationale for estrogen with interrupted progestin as a new low-dose hormonal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Steroid receptor levels in intact and ovariectomized estrogen-treated rats: an examination of quantitative, temporal and endocrine factors influencing the efficacy of an estradiol stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Tissue-specific regulation of rat estrogen receptor mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Progesterone Regulation of the Occupied Form of Nuclear Estrogen Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Progesterone-modulation of estrogen action: rapid down regulation of nuclear acceptor sites for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

The effect of different hormone replacement therapy regimens on the mechanical properties of rat vertebrae

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Effects of different estrogen and progestin regimens on the mechanical properties of rat femur

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900076-6

7 January 2021

10.1016/S0378-5122(99)00076-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10714903